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The prohormone vitamin D is best known for its key role in the 
metabolism of calcium and phosphate.[1] In critically ill patients, 
the potential to influence outcome through its pleiotropic effects 
on bone, muscle, cardiac and immunological function (where it is 
stimulatory to the innate but immunomodulatory to the adaptive 
immune system) has created interest in the use of vitamin D in the 
intensive care unit (ICU) among intensivists.[2,3] 
Vitamin D deficiency is highly prevalent in ICU patients, with a 
prevalence of 50 - 82%, and is associated with increased inflammatory 
markers, multi-organ dysfunction, immune dysregulation and 
poorer outcomes.[1,2,4-7] Elevated inflammatory markers, particularly 
C-reactive protein (CRP) and procalcitonin (PCT), occur with 
vitamin D deficiency.[8] A Brazilian cohort of critically ill patients with 
25-hydroxyvitamin D (25(OH)D) levels <12 ng/mL had increased 
organ system dysfunction and a greater change in sequential organ 
failure assessment (SOFA) score.[9,10] Furthermore, observational 
studies have shown an independent association between vitamin D 
deficiency and mortality.[9,10] In meta-analyses examining vitamin D 
deficiency among critically ill patients, increased rates of infection, 
sepsis and mortality have been noted.[5,7]
Randomised controlled trials (RCTs) that have investigated 
vita min D supplementation in deficient critically ill patients have 
shown little benefit. The VITdAL-ICU (Effect of High-Dose Vitamin D3 
on Hospital Length of Stay in Critically Ill Patients with Vita -
min D Deficiency) RCT that assessed outcomes of critically ill vita min 
D-deficient patients following vitamin D supplementation did not 
demonstrate improvement in length of hospital stay, hospital mortality 
or 6-month mortality, except in severely vitamin D-deficient patients 
(25(OH)D <12 ng/mL), where mortality was reduced (hazard ratio 
(HR) 0.56 (95% confidence interval (CI) 0.35 - 0.90)).[11] Moreover, 
in patients supplemented with vitamin D, median inflammatory 
marker levels were reduced on day 28 compared with placebo (CRP 51 v. 
32 mg/L (p=0.04); PCT 0.2 v. 0.1 ng/mL (p=0.05)).[11] In contrast, no 
improved 90-day mortality outcome was noted in the recent VIOLET 
(Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient 
Patients) double-blind, placebo-controlled RCT of early vitamin D3 
supplementation with a single enteral dose of 540 000 IU vitamin D3 
compared with placebo in vitamin D-deficient (25(OH)D <20 ng/mL) 
critically ill patients.[12] 
Recent data have illustrated that vitamin D deficiency (25(OH)D 
<15 ng/mL) during early critical illness is crucial in the regulation 
of glutathione and glutamate pathways. Both pathways influence 
glutamine metabolism and ultimately serum glutamine levels.[13] 
There is no consensus with regard to the data examining glutamine 
supplementation in critically ill patients. Some studies have shown 
reduced infection rates, ICU and hospital stay, and mortality 
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Background. Vitamin D deficiency is common in intensive care unit (ICU) patients (50 - 82%) and is associated with multi-organ 
dysfunction. Vitamin D deficiency alters pathways of glutamine metabolism in critical illness, but the impact of vitamin D status on 
glutamine levels is poorly characterised. 
Objectives. To assess the prevalence of vitamin D deficiency and its association with organ dysfunction and glutamine levels in a South 
African (SA) ICU.
Methods. Records of 103 adult patients admitted to the Wits Donald Gordon Medical Centre ICU, Johannesburg, SA were retrospectively 
reviewed. 25-hydroxyvitamin D (25(OH)D) and glutamine levels were measured on admission. The association between admission vitamin 
D levels and glutamine levels, illness severity scores, organ support and outcomes was examined. 
Results. On ICU admission, 66% (68/103) of patients were vitamin D deficient (<20 ng/mL) (95% confidence interval (CI) 56 - 75). Vitamin 
D deficiency was significantly associated with mechanical ventilation (40% v. 14%) (p=0.013) and a higher median sequential organ failure 
assessment (SOFA) score on admission (6 (interquartile range (IQR) 3 - 8) v. 4 (IQR 2 - 6)) (p=0.047) and on day 7 (5 (IQR 2 - 10) v. 2 
(IQR 1 - 4)) (p=0.017). Median admission serum glutamine levels were 481 µmol/L, with 38% deficient (<420 µmol/L) (95% CI 28 - 48). 
Vitamin D deficiency status on admission was not significantly associated with median admission glutamine levels (p=0.66). 
Conclusions. Vitamin D deficiency is common in ICU patients in SA. Deficient patients were more severely ill and required more 
respiratory support. No significant relationship between deficiency and median glutamine levels was noted.
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after vitamin D supplementation, while other studies have noted 
increased mortality rates.[14-18] Experts have argued that the benefits 
of glutamine supplementation in critically ill patients cannot yet be 
discounted, as a U-shaped curve is noted when comparing glutamine 
levels with outcomes. Serum glutamine levels should be targeted to a 
specific range for beneficial effects to be noted. Hence, understanding 
initial admission glutamine levels in patients admitted to the ICU is 
necessary to enable treating physicians to identify patients who may 
benefit from glutamine supplementation.[19] As vitamin D deficiency 
may influence serum glutamine levels, it is of value to elucidate 
the interaction between vitamin D and glutamine metabolism in 
critically ill patients to determine the effect of vitamin D deficiency 
on glutamine levels and the potential threshold for glutamine 
supplementation. 
There are few South African (SA) data examining the prevalence 
of vitamin D deficiency and the impact on clinical outcomes, 
inflammatory markers and organ dysfunction in critically ill patients. 
This is of particular interest, as SA is a high ultraviolet B (UVB) light 
region, where rates of vitamin D deficiency are thought to be low.[20] 
Furthermore, to our knowledge, no studies have compared baseline 
vitamin D and glutamine levels, despite evidence suggesting a 
metabolic link between the two. Due to the heterogeneous multiracial 
and multi-ethnic patient population in SA, this lack of data represents 
an opportunity to add to the current growing international literature 
on vitamin D and glutamine in critically ill patients.
Methods
This observational retrospective study reviewed the clinical and 
biochemical records of medical and surgical patients admitted to 
the Wits Donald Gordon Medical Centre ICU in Johannesburg, SA, 
from January 2018 to July 2018. Adult patients ≥18 years of age with 
baseline data recorded within 24 hours of admission, and who were 
admitted for a minimum of 3 days, were included. Patients for whom 
data were incomplete or insufficient, or whose necessary biochemical 
parameters were not measured, were excluded. 
Study definitions and measures
Patients included in the study were defined as those admitted to the 
ICU for either acute organ support or acute postoperative care after 
major surgery. The following were extracted from clinical records: 
demographics, anthropometrical measurements, body mass index 
(BMI), (classified by the World Health Organization (WHO)),[21] 
clinical diagnosis based on the patient’s profile when admitted to the 
ICU (chronic liver disease, colorectal cancer (CRC), hepatobiliary 
cancer, chronic kidney disease (CKD) and other diagnoses), primary 
reason for admission to the ICU (medical or surgical), acute 
physiology and chronic health evaluation (APACHE) II score on 
admission and SOFA scores on admission and day 7, duration of ICU 
and hospital stay, need for organ support (ventilation, vasopressors 
or inotrope agents and haemodialysis) and mortality outcome. The 
results of inpatient blood sampling, i.e. admission biochemistry, 
admission glutamine and 25(OH)D levels, were also recorded. 
Serum levels of 25(OH)D were measured to evaluate vitamin D 
status due to its greater reliability, longer half-life and greater plasma 
concentrations.[1,22] The Abbott Architect 25(OH)D chemiluminescent 
microparticle immunoassay (Abbott Laboratories, Germany) was 
used to measure serum 25(OH)D concentrations. Serum 25(OH)D 
levels <20 ng/mL were classified as deficient, 20 - 30 ng/mL as 
insufficient and >30 ng/mL as sufficient.[1,2,13] Serum glutamine levels 
were analysed, using liquid chromatography-mass spectrometry, 
at the central analytical facilities, Stellenbosch University, SA. All 
samples were centrifuged within 30 minutes and stored at ‒80°C 
until analysed. Glutamine levels <420 µmol/L were categorised as 
deficient.[24] 
Sample size
Sample size estimation is based on key research questions to be 
answered, in this case: (i) estimation of the prevalence of vitamin D 
deficiency; and (ii) association between categorised baseline vita- 
min D levels and categorical variables. For the first question, based 
on worst-case (for sample size) estimates of 50%, 5% precision and 
the 95% CI level, a sample size of n=385 would be required; the actual 
sample size of n=103 corresponds with a precision of 9.7% – not 5%. 
For the second question, Fisher’s exact test is required for most tests 
of association (2 × 2 tables). For the detection of a medium effect 
size (w=0.3), should it exist, with 80% power at a significance level 
of p<0.05, a minimum sample size of n=87 is required. The actual 
sample size of n=103 allows the detection of a slightly larger effect 
size. Sample size calculations were carried out in G*Power.[25] 
Data analysis
For comparison with the vitamin D-deficient group, the insufficient 
and sufficient groups were combined owing to small group sizes. The 
χ2 test was used to assess the relationship between categorised vitamin D 
levels and categorical variables. Fisher’s exact test was used for 2 × 2 tables. 
The relationship between categorised vitamin D levels and continuous 
variables was assessed by the Wilcoxon rank sum test. The correlation 
between vitamin D and glutamine levels was assessed by Spearman’s 
correlation coefficient. Data analysis was carried out using SAS 
version 9.4 for Windows (Microsoft, USA). A significance level of 
p<0.05 was used. 
Ethical approval
The University of the Witwatersrand Human Research Ethics 
Committee approved this study (ref. no. M181129).
Results
From January 2018 to July 2018, 120 adult patients met the 
study inclusion criteria. Of these, 17 were subsequently excluded 
owing to insufficient clinical information, leaving a final total of 
103 study patients. The median age was 57 years (inter quartile 
range (IQR) 44 - 67). An equal representation of genders and 
medical and surgical patients was seen. The median admission 
APACHE II and SOFA scores were 13 (IQR 8 - 18) and 5 (IQR 
5 - 7), respectively. The largest group of patients had chronic 
liver dysfunction (36%); of these, 49% had acute liver failure or 
acute decompensation of chronic liver failure, while 35% had 
undergone liver transplantation. The second largest group of 
patients had cancer: 27% had CRC and were admitted after major 
colorectal surgery, whereas 7% had hepatobiliary cancer and were 
admitted after pancreaticoduodenectomy. Among those with CKD, 
64% were admitted with sepsis, while 36% had undergone renal 
transplantation. Admission demographic, anthropometric and 
clinical characteristics are shown in Table 1. 
On admission, 66% of this cohort were vitamin D deficient 
(95% CI 56 - 75) (Fig. 1). When these patients were compared by 
race, gender, BMI, primary diagnosis and reason for ICU admission, 
no significant differences between groups were observed (Table 1). 
In this cohort, the prevalence of glutamine deficiency was 38% 
(95% CI 28 - 48); however, there was no significant association 
between admission median serum glutamine levels and vitamin D 
status (Spearman’s Rho ‒0.097; p=0.32) (Table 2). 
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On admission to the ICU, a significantly higher 
median SOFA score was noted in the vita-
min D-deficient group (Table 2). How ever, no 
significant differences between the two groups 
in median levels of inflammatory markers, 
renal function and liver function were seen 
(Table 2). The use of mechanical ventilation was 
significantly higher in the vitamin D-deficient 
group (p=0.013), while increased vasopressor 
use was not significant (p=0.069) (Fig. 2). 
In the entire cohort, the median length of 
ICU stay was 7 (IQR 5 - 10) days and the 
mortality rate 15%. Comparing patients as 
vitamin D-deficient v. insufficient/suffi cient, 
showed no significant difference in outcome 
measures. However, in the vita min D-deficient 
group the median day 7 SOFA score remained 
significantly higher (Table 3). 
Discussion
In this SA cohort, 66% of patients admitted 
to the ICU were vitamin D deficient and 
38% were glutamine deficient. Vitamin 
D-deficient patients had higher median 
SOFA scores on admission and on day 7 
of ICU stay. They also required increased 
mechanical ventilation; however, no impact 
on median ICU length of stay or mortality was 
noted. There was no significant relationship 
between vitamin D and glutamine status on 
admission. 
We noted a high prevalence of vita min D 
deficiency, which was similar to that in 
other studies.[1,2,4-7] Vitamin D deficiency 
among ICU patients remained high, even 
with high UVB light exposure in SA.[20] This 
result is similar to results in other studies, 
where, regardless of the degree of UVB 


























Fig. 1. Vitamin D and glutamine status on admission to the ICU (N=103).
Table 1. Patient characteristics compared with vitamin D status on admission (N=103)
 Patient characteristics Total  (N=103), n (%)




sufficient, ≥20 ng/mL 
(n=35), n (%) p-value*
Age, years
≤65 74 (72) 49 (72) 25 (71) >0.99
>65 29 (28) 19 (28) 10 (29)
Ethnicity        
White 67 (65) 42 (62) 25 (71) 0.58
Black 21 (20) 16 (24) 5 (14)
Asian 13 (13) 9 (13) 4 (11)
Coloured 2 (2) 1 (1) 1 (3)
Gender        
Male 51 (49) 38 (56) 13 (37) 0.096
Female 52 (51) 30 (44) 22 (63)
Body mass index        
Underweight (<18.5 kg/m2) 4 (4) 28 (41) 17 (49) 0.40†
Normal weight (18.5 - 25 kg/m2) 41 (40)
Overweight (25.1 - 30 kg/m2) 32 (31) 20 (29) 12 (34)
Obese (>30 kg/m2) 26 (25) 20 (29) 6 (17)
Reason for admission        
Medical 50 (48) 35 (51) 15 (43) 0.53
Surgical 53 (52) 33 (49) 20 (57)
Underlying diagnosis        
Chronic liver disease 37 (36) 29 (43) 8 (23) 0.27
Colorectal cancer 28 (27) 15 (22) 13 (37)
Chronic kidney disease 14 (14) 8 (12) 6 (17)
Hepatobiliary cancer 7 (7) 5 (7) 2 (6)
Other 17 (17) 11 (16) 6 (17)
*Fisher’s exact test, unless otherwise indicated.
†χ2 test. 
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deficiency in critically ill patients remained 
high.[26] Intriguingly, in populations 
with longer winter periods, where food 
fortification, consumption of fatty fish and 
use of supplements are greater owing to 
awareness around vitamin D status and its 
health implications, vitamin D deficiency 
is less prevalent. We postulate that, despite 
sunlight exposure, a lack of vitamin D supple -
mentation among chronically ill patients 
due to reduced awareness of vitamin D 
deficiency may have contributed to its high 
prevalence in our study.[27] Individuals with 
high melanin levels of the skin notably 
have higher rates of vitamin D deficiency; 
however, we noted no racial differences 
regarding the prevalence of vitamin D defi-
ciency in ICU patients.[27] 
We observed higher illness severity scores 
and an increased need for mechanical 
ventilation among vitamin D-deficient 
ICU patients, as in other observational 
studies.[3,28-30) Vitamin D has been shown 
to be protective to the alveolar epithelial 
layer and to reduce alveolar inflammation.[31,32] 
Hence, the increased rates of mechanical 
ventilation we observed may be explained 
by loss of alveolar epithelial structural 
integrity in deficient patients.[31,32] Despite 
the immunomodulatory function of 
vitamin D, we observed no significant asso-
ciation between vitamin deficiency and 
inflammatory markers (CRP and PCT), 
which was also noted in some studies.[33,34] 
However, our findings are in contrast with 
those in other studies, where patients with 
sepsis and vitamin D deficiency had a 
negative correlation between inflammatory 
markers and vitamin D levels.[29,30] The 
absence of an association in our cohort may 
be explained by the absence of sepsis in 
many patients at initial presentation. 
Table 2. Admission prognostic scores, biochemistry and glutamine levels compared with vitamin D status (N=103)
  Vitamin D deficient (<20 ng/mL),
median (IQR)
Vitamin D insufficient/sufficient 
(≥20 ng/mL), median (IQR) p-value*
SOFA 6 (3 - 8) 4 (2 - 6) 0.047
APACHE II 15 (8 -19) 11 (8 - 16) 0.28
C-reactive protein, mg/dL 28 (7 - 74) 20 (4 - 92) 0.76
Procalcitonin, µg/L 0.72 (0.23 - 1.96) 0.85 (0.24 - 1.74) 0.99
Urea, mmol/L 7.0 (4.5 - 16.3) 5.8 (4.2 - 13.7) 0.44
Creatinine, µmol/L 100 (74 - 202) 94 (62 - 290) 0.69
Albumin, g/L 31 (27 - 33) 29 (22 - 35) 0.63
Bilirubin, µmol/L 21 (10 - 39) 13 (9 - 24) 0.12
Alanine aminotransferase, U/L 26 (16 - 171) 21 (15 - 41) 0.17
Aspartate aminotransferase, U/L 33 (21 - 222) 28 (20 - 52) 0.23
Alkaline phosphatase, U/L 82 (58 - 134) 85 (54 - 142) 0.93
Glutamine, µmol/L 486 (374 - 702) 469 (357 - 701) 0.66
IQR = interquartile range; SOFA = sequential organ failure assessment; APACHE II = acute physiology and chronic health evaluation.
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Fig. 2. Association between organ support and vitamin D status on admission to the ICU (N=103) 
(Fisher’s exact test).
Table 3. Outcomes compared with admission vitamin D status
 Outcomes Vitamin D deficient, <20 ng/mL Vitamin D insufficient/sufficient, ≥20 ng/mL p-value*
Length of ICU stay (days), median (IQR) 7 (5 - 9) 6 (4 - 12) 0.91
Length of hospital stay (days), median (IQR) 11 (8 - 24) 13 (7 - 22) 0.80
SOFA (day 7), median (IQR) 5 (2 - 10) 2 (1 - 4) 0.017
Mortality, n (%) 11 (16) 4 (11) 0.77†
ICU = intensive care unit; IQR = interquartile range; SOFA = sequential organ failure assessment. 
*Wilcoxon rank sum test, unless otherwise indicated.
†Fisher’s exact test.
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25(OH)D is produced in the liver after metabolism of vitamin D3 via 
the cytochrome P450 enzyme pathway.[3] Patients with chronic liver 
disease are predisposed to vitamin D deficiency owing to numerous 
mechanisms, e.g. malnutrition, malabsorption, low levels of binding 
proteins and impaired hydroxylation of 25(OH)D.[3,35] There was 
a high prevalence of vitamin D deficiency among patients with 
chronic liver disease (78%), similar to the findings of Mayr et al.[35] 
In their study, 72% of ICU patients with chronic liver disease 
were vita min D deficient, with a greater prevalence among those 
with cirrhosis (74%) compared with non-cirrhotic patients (45%). 
Furthermore, they suggest that 25(OH)D levels <10 ng/dL appear 
to be a risk factor for mortality in chronic liver disease, especially 
in patients with cirrhosis. Mayr et al.[35] also noted that vitamin D 
supplementation prior to ICU admission reduced 180-day mortality 
(HR 0.46; 95% CI 0.29 - 0.73; p< 0.001). However, following a post 
hoc analysis of the VITdAL-ICU RCT, there was no improvement 
in vitamin D levels or outcomes in critically ill patients with liver 
cirrhosis after vitamin D supplementation. This observation is 
limited by the small sample size (n=23). Further research is necessary 
in patients with chronic liver disease, who have a high risk and 
prevalence of vitamin D deficiency, to determine if outcomes may be 
improved with vitamin D supplementation during critical illness.[36]
Vitamin D deficiency is associated with increased CRC risk, and 
improved CRC outcomes have been shown in a RCT following 
supplementation.[37] Vitamin D levels were shown to decline in the 
immediate postoperative period in a Scottish cohort of 92 CRC 
patients. Furthermore, Vaughan-Shaw et al.[37] performed a meta-
analysis of 4 106 patients, demonstrating that vitamin D deficiency 
was associated with increased postoperative CRC mortality (HR 0.69; 
95% CI 0.46 - 0.91) and all-cause mortality (HR 0.68; 95% CI 0.50 - 
0.85), which was independent of postoperative inflammation. In CRC 
patients with the VDR rs11568820 GG genotype, increased mortality 
was associated with lower vitamin D levels (HR 0.51; 95% CI 0.21 - 
0.81).[37] These findings support a causal relationship between a poorer 
outcome in CRC and vitamin D deficiency. As 54% of our patients with 
CRC were vitamin D deficient, this lends support to the recommendation 
by Vaughan-Shaw et al.[37] for a RCT on survival outcome with vitamin D 
supplementation after CRC surgery in deficient patients. 
A recent study examined the metabolic profiles of critically ill patients 
in relation to early vitamin D status. Of interest, Lasky-Su et al.[13] noted 
that among those with 25(OH)D levels <37.5 nmol/L (15 ng/mL), and 
the presence of a systemic inflammatory response, metabolic pathways 
affecting glutamine metabolism were significantly altered.[3] This 
interaction is of particular interest in critically ill patients. However, 
observational studies, meta-analyses and RCTs suggest the presence 
of a U-shaped relationship between glutamine levels and outcome, 
as both glutamine deficiency and excess levels are associated with 
worse outcomes.[18,38,39] Therefore, it is pertinent to determine the 
influence of vitamin D on glutamine metabolism and ultimately 
serum glutamine levels, as this would further assist in clarifying any 
potential role of glutamine in critically ill patients. Despite the lack of 
an association between glutamine and vitamin D levels in this cohort 
of ICU patients, further studies are needed to clarify this potential 
interaction. 
Study limitations
Our study is limited by the retrospective design and small study 
sample size, as well as the fairly unique and predominately 
postoperative patient population in our ICU. These factors, as 
well as the predominance of gastroenterology, hepatobiliary and 
renal pathology in our cohort, may make it difficult to extrapolate 
the findings to other ICUs. The large proportion of patients with 
chronic liver disease may have contributed to the low CRP levels. 
Furthermore, the measurement of 25(OH)D in CKD patients as opposed 
to 1.25 dihydroxyvitamin D may underestimate the prevalence of 
vitamin D deficiency in this population. The use of an immunoassay 
and not liquid chromatography-mass spectrometry to measure 
vitamin D levels is a potential limitation. Moreover, a comparison of 
glutamine and vitamin D levels after supplementation would be of 
value to clarify any potential metabolic relationship and implications 
of vitamin D supplementation on glutamine levels in a real-life 
clinical setting. 
Conclusions
Despite high UVB light exposure in SA, vitamin D deficiency and 
glutamine deficiency are highly prevalent in patients on admission 
to the ICU. The vitamin D-deficient group was more severely ill 
and a greater number required mechanical ventilation. Despite 
a possible link between vitamin D and glutamine metabolism, 
no significant association between vitamin D levels and plasma 
glutamine concentration was observed. 
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